Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

LON/0SGC stock hub

LON/0SGC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0SGCis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

627.3M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0SGC

In the news

Latest news · LON/0SGC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-38.5

P25 n/aP50 n/aP75 n/a

ROIC-18.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0SGC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

152

Groups with data

Currency

USD

Showing 152 of 152 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	UK
Employees	19
Employees Change	-25%
Employees Change Percent	-56.82
Enterprise value	$563.2M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	$627.3M
Price	$3.32
Price currency	USD
Rev Per Employee	550,719.42x
Sic	2836
Symbol	lon/0SGC
Website	https://www.arbutusbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.97%
EV Earnings	-22.63x
EV/Sales	54.49x
P/B ratio	11.02x
P/S ratio	59.95x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-192.08%
EBITDA Margin	-189.51%
Gross margin	-79.23%
Gross Profit	$-8.3M
Net Income	$-24.9M
Pretax Margin	-237.88%
Profit Margin	-237.88%
Profit Per Employee	$-1.3M
ROA	-14.94
Roa5y	-24.26
ROCE	-30.53
ROE	-38.52
Roe5y	-53.76
ROIC	-18.35

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	34.95%
Cagr3y	5.23%
Revenue Growth	128.21x
Revenue Growth Q	-33.23x
Revenue Growth3 Y	-28.8x
Revenue Growth5 Y	15.29x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.12
Assets	$70.3M
Cash	$68M
Current Assets	$69.3M
Current Liabilities	$4.4M
Debt	$3.1M
Debt Equity	$0.05
Equity	$56.9M
Interest Coverage	-278.9
Liabilities	$13.4M
Long Term Assets	$1M
Long Term Liabilities	$9M
Net Cash	$64.9M
Net Cash By Market Cap	$10.34
Net Cash Growth	-25.08%
Net Debt Equity	$-1.14
Tangible Book Value	$56.9M
Tangible Book Value Per Share	$0.3

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	15.73
Net Working Capital	$-1.8M
Quick ratio	15.52
Working Capital	$65.7M
Working Capital Turnover	$0.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.23%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	35.03%
200-day SMA	3.46
3Y total return	16.54%
50-day SMA	3.39
50-day SMA vs 200-day SMA	50under200
All Time High	6.47
All Time High Change	-48.7%
All Time High Date	2021-12-01
All Time Low	1.7
All Time Low Change	95.24%
All Time Low Date	2023-11-13
ATR	0.08
Ch YTD	1.65
High	3.32
High52	4.68
High52 Date	2024-09-09
High52ch	-29.01%
Low	3.28
Low52	2.37
Low52 Date	2024-02-01
Low52ch	40.34%
Ma50ch	-2.07%
Price vs 200-day SMA	-4.16%
RSI	49.03
RSI Monthly	53.81
RSI Weekly	47.65
Sharpe ratio	1.42x
Sortino ratio	2.65
Total Return	-3.23%
Tr YTD	1.65
Tr1m	4.87%
Tr1w	-0.07%
Tr3m	-16.29%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-20.1M
Operating margin	-192.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	126,693,713%
Shares Insiders	1.53%
Shares Institutions	49.97%
Shares Qo Q	0.3%
Shares Yo Y	3.23%
Short Ratio	7.92

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1,639.6x
Bv Per Share	0.3
Ch1m	4.87
Ch1w	-0.06
Ch1y	35.03
Ch3m	-16.29
Ch3y	16.54
Ch6m	-10.78
Change	0.3%
Change From Open	1.19
Close	3.31
Days Gap	-0.88
Depreciation Amortization	266,265.6
Dollar Volume	2,509.2
Earnings Date	2026-05-14
EBIT	$-20.1M
EBITDA	$-19.8M
EPS	$-0.13
F Score	4
Financing CF	4,250,703
Fiscal Year End	December
Founded	2,005
Investing CF	11,575,940
Is Primary Listing	0
Last Earnings Date	2025-11-06
Last Report Date	2025-12-31
Ma150	3.64
Ma150ch	-8.82%
Ma20	3.31
Ma20ch	0.33%
Net CF	-13,613,246
Next Earnings Date	2026-05-14
Open	3.28
Position In Range	100
Ppne	23,472.4
Price Date	2025-01-31
Ptbv Ratio	11.02
Relative Volume	0.46x
Revenue	10,463,669x
SBC By Revenue	49.37x
Share Based Comp	5,166,079
Tr6m	-10.78%
Volume	756
Z Score	3.54

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0SGC pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0SGC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0SGC?

Insider, institutional, and short-interest positioning.

Institutional ownership

+50.0%

Share of float held by funds and institutions

Insider ownership

+1.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0SGC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.0

Neutral momentum band

Price vs 200-day MA

-4.2%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.42

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0SGC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0SGC stock rating?

lon/0SGC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0SGC analysis?

The full report lives at /stocks/lon/0SGC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0SGC?

The latest report frames lon/0SGC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0SGC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.